Conference Description

June 2, 2007
Sheraton Cypress Creek
555 Northwest 62nd Street
Ft. Lauderdale, FL
866-716-8106

Tell a friend about this conference

Download the brochure for this conference

CME Credits: 3.5*

Nonrefundable registration fee: $0.

Target Audience: Gastroenterologists and Primary Care Providers.

Program Summary:

The topics chosen for this program, New Perspectives in the Management of Gastro intestinal Diseases: Update 2007, reflect subjects of significant interest to health care providers involved in the treatment of gastrointestinal diseases. There is a need for providers to be aware of new developments that are rapidly emerging in this field involving diagnostic and therapeutic treatments. A compre - hensive needs assessment identified the need for additional information in the treatment of Hepatitis C, Irritable Bowel Syndrome, Barrett’s Esophagus, Inflam matory Bowel Disease and use of biologics, the use of NSAIDS, and issues in managed care.

Learning Objectives:
At the conclusion of this program, participants should be able to:

1. discuss current trends and treatment for Hepatitis C
2. identify current thinking on irritable bowel syndrome and evolving strategies for treatment
3. recognize risks and benefits of NSAIDs, ASA, and Cox-2 Inhibitors
4. discuss approaches to the diagnosis and treatment of Barrett’s esophagus and new endoscopic modalities for reflux disease
5. describe the utilization of new strategies to optimize treatment in diagnosis of inflammatory bowel disease
6. discuss anatomy of the lower bowel and biological concerns related to anal disorders in order to treat medically and prevent the need for surgical intervention
7. describe issues involving managed care and treatment of GI disorders

Agenda:
Saturday, June 2, 2007

7:45-8:30 am		Registration, Continental Breakfast and Welcome
8:30-9:00		Hepatitis C To Treat, Biopsy or Watch: Matching which patient with which option Christopher O’Brien, MD
9:00-9:30		Irritable Bowel Syndrome: Exploring the brain inside our gut Matthew Soff, MD
9:30-10:00		NSAIDs and the Heart and Gut H. Juergen Nord, MD
10:00-10:15		Q & A
10:15-10:30		Break
10:30-11:00		Barrett’s Esophagus: Are we beating a dead horse? Richard E. Sampliner, MD
11:00-11:30		Inflammatory Bowel Disease Therapy in the Era of Biologics Patricia Kozuch, MD
11:30-12:00		Managing Managed Care: The mega-Group as a modality in the managed care arena Gary S. Luckman, MD
12:00-12:15		Q & A

Faculty:
Patricia Kozuch, MD
Assistant Professor of Medicine
Thomas Jefferson University Hospital/Jefferson Medical College
Philadelphia, PA

Gary S. Luckman, MD
President GastroCare
Plantation, FL

H. Juergen Nord, MD
Professor of Medicine
USF College of Medicine
Tampa, FL

Christopher O’Brien, MD
Professor of Medicine
University of Miami Hospital and Clinics
Miami Veterans Affairs Medical Center
Miami, FL

Richard E. Sampliner, MD
Professor, Medicine
Department of Medicine
University of Arizona College of Medicine
Tucson, AZ

Mathew Soff, MD
Community Gastroenterologist
Plantation, FL

Course Directors: Matthew Soff, MD and Herbert Cohen, MD

Activity Director: Michelle Frisch, MPH

*Continuing Education Information
Application for CME credit has been filed with the American Academy of Family Physicians. Determination of credit is pending.

This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Massachusetts Medical School (UMMS) and the National Association for Continuing Education. The University of Massachusetts Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Massachusetts Medical School designates this educational activity for a maximum of 3.5 AMA PRA Category I Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Under the auspices of the University of Massachusetts Medical School Office of Continuing Education this offering meets the requirements for 3.5 contact hours, as specified by the Massachusetts Board of Registration in Nursing (244- CMR 5.04). Each nurse should claim only those hours of credit that he/she actually spent in the educational activity.

Policy on Faculty and Provider Disclosure: It is the policy of the University of Massachusetts Medical School to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the University of Massachusetts Medical School are required to present evidenced- based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure will be provided in the activity materials.

This program was supported through educational grants from the following companies: Amgen, Shire, Takeda, TAP, Wyeth.